Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

LARC in Women Treated for Opioid Use Disorder

Contraception; ePub 2017 Aug 2; Matusiewicz, et al

Among women in medication-assisted treatment (MAT) for opioid use disorder, there was relatively low interest and lack of information regarding safety and effectiveness of long-acting reversible contraception (LARC), a recent study found. Women in MAT completed a survey on contraceptive use, attitudes, and knowledge, including LARC methods, as part of eligibility screening for an ongoing trial evaluating family planning interventions for this population. Researchers found:

  • 83 women completed the survey; 51 completed supplemental questions about implants.
  • All participants had heard of IUDs and 75 (90%) knew of implants, but only 34 (41%) and 14 (27%) reported being likely to use IUDs and implants, respectively.
  • Many women had unspecified reasons for not using LARCs.
  • Only 50 (60%) women were aware of the superior effectiveness of IUDs and 26 (51%) were aware of the superior effectiveness of implants relative to other reversible methods.

Citation:

Matusiewicz AK, Melbostad HS, Heil SH. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder. [Published online ahead of print August 2, 2017]. Contraception. doi:10.1016/j.contraception.2017.07.167.